REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $13,459,131 | -38.4% | 729,097 | -9.8% | 0.38% | -40.4% |
Q3 2022 | $21,834,000 | +176.0% | 808,671 | +41.2% | 0.63% | +155.6% |
Q2 2022 | $7,912,000 | +195.0% | 572,514 | +316.3% | 0.25% | +359.3% |
Q1 2022 | $2,682,000 | +66.8% | 137,514 | +108.9% | 0.05% | +107.7% |
Q2 2020 | $1,608,000 | -88.3% | 65,839 | -92.9% | 0.03% | -92.7% |
Q1 2020 | $13,690,000 | +2.8% | 925,000 | +12.8% | 0.36% | +35.2% |
Q4 2019 | $13,315,000 | -30.2% | 820,377 | +32.5% | 0.26% | -50.6% |
Q1 2018 | $19,064,000 | +33.3% | 618,957 | +54.7% | 0.53% | +12.7% |
Q4 2017 | $14,300,000 | – | 400,000 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,228,609 | $59,972,145 | 5.67% |
Essex Woodlands Management, Inc. | 457,085 | $5,242,765 | 4.62% |
Ghost Tree Capital, LLC | 350,000 | $4,014,500 | 1.32% |
AlphaCentric Advisors LLC | 190,000 | $2,179,300 | 1.24% |
Sio Capital Management, LLC | 342,477 | $3,928,211 | 1.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 288,726 | $3,308,800 | 1.12% |
Rubric Capital Management LP | 1,600,000 | $18,352,000 | 0.69% |
RICE HALL JAMES & ASSOCIATES, LLC | 683,937 | $7,844,757 | 0.50% |
Rhenman & Partners Asset Management AB | 361,679 | $4,148,458 | 0.45% |
Polar Capital Holdings Plc | 4,160,311 | $47,718,767 | 0.35% |